178 related articles for article (PubMed ID: 18224529)
1. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation.
Koc K; Anik I; Cabuk B; Ceylan S
Br J Neurosurg; 2008 Feb; 22(1):99-103. PubMed ID: 18224529
[TBL] [Abstract][Full Text] [Related]
2. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note.
Shinoda J; Yano H; Yoshimura S; Okumura A; Kaku Y; Iwama T; Sakai N
J Neurosurg; 2003 Sep; 99(3):597-603. PubMed ID: 12959452
[TBL] [Abstract][Full Text] [Related]
4. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.
Butowski N; Lamborn KR; Berger MS; Prados MD; Chang SM
J Neurooncol; 2007 Oct; 85(1):87-94. PubMed ID: 17457513
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma.
Fan C; Jiang Y; Liu R; Wu G; Wu G; Xu K; Miao Z
Clin Neurol Neurosurg; 2018 Dec; 175():57-60. PubMed ID: 30384117
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-ALA dose on resection of glioblastoma.
Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
[TBL] [Abstract][Full Text] [Related]
8. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
[TBL] [Abstract][Full Text] [Related]
9. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
10. Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection.
Prada F; Bene MD; Fornaro R; Vetrano IG; Martegani A; Aiani L; Sconfienza LM; Mauri G; Solbiati L; Pollo B; DiMeco F
Neurosurg Focus; 2016 Mar; 40(3):E7. PubMed ID: 26926065
[TBL] [Abstract][Full Text] [Related]
11. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
13. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein-Guided Surgery for High-Grade Glioma Resection: An Intraoperative "Contrast-Enhancer".
Catapano G; Sgulò FG; Seneca V; Lepore G; Columbano L; di Nuzzo G
World Neurosurg; 2017 Aug; 104():239-247. PubMed ID: 28512039
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.
Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ
J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842
[TBL] [Abstract][Full Text] [Related]
16. Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.
Amelot A; Deroulers C; Badoual M; Polivka M; Adle-Biassette H; Houdart E; Carpentier AF; Froelich S; Mandonnet E
Neurosurgery; 2017 May; 80(5):793-799. PubMed ID: 28387870
[TBL] [Abstract][Full Text] [Related]
17. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].
Jeremić B; Grulicić D; Samardzić M; Antunović V; Joksimović M; Djurić Lj; Milicić B; Nikolić N
Srp Arh Celok Lek; 1997; 125(3-4):93-8. PubMed ID: 9221525
[TBL] [Abstract][Full Text] [Related]
18. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
[TBL] [Abstract][Full Text] [Related]
19. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
20. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.
Hong B; Wiese B; Bremer M; Heissler HE; Heidenreich F; Krauss JK; Nakamura M
Am J Clin Oncol; 2013 Jun; 36(3):261-8. PubMed ID: 22495452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
